Literature DB >> 12972407

Hypoxia-induced acute lung injury in murine models of sickle cell disease.

Kirkwood A Pritchard1, Jingsong Ou, Zhijun Ou, Yang Shi, James P Franciosi, Paul Signorino, Sushma Kaul, Cathleen Ackland-Berglund, Karin Witte, Sandra Holzhauer, Narla Mohandas, Karen S Guice, Keith T Oldham, Cheryl A Hillery.   

Abstract

Vaso-occlusive events are the major source of morbidity and mortality in sickle cell disease (SCD); however, the pathogenic mechanisms driving these events remain unclear. Using hypoxia to induce pulmonary injury, we investigated mechanisms by which sickle hemoglobin increases susceptibility to lung injury in a murine model of SCD, where mice either exclusively express the human alpha/sickle beta-globin (halphabetaS) transgene (SCD mice) or are heterozygous for the normal murine beta-globin gene and express the halphabetaS transgene (mbeta+/-, halphabetaS+/-; heterozygote SCD mice). Under normoxia, lungs from the SCD mice contained higher levels of xanthine oxidase (XO), nitrotyrosine, and cGMP than controls (C57BL/6 mice). Hypoxia increased XO and nitrotyrosine and decreased cGMP content in the lungs of all mice. After hypoxia, vascular congestion was increased in lungs with a greater content of XO and nitrotyrosine. Under normoxia, the association of heat shock protein 90 (HSP90) with endothelial nitric oxide synthase (eNOS) in lungs of SCD and heterozygote SCD mice was decreased compared with the levels of association in lungs of controls. Hypoxia further decreased association of HSP90 with eNOS in lungs of SCD and heterozygote SCD mice, but not in the control lungs. Pretreatment of rat pulmonary microvascular endothelial cells in vitro with xanthine/XO decreased A-23187-stimulated nitrite + nitrate production and HSP90 interactions with eNOS. These data support the hypotheses that hypoxia increases XO release from ischemic tissues and that the local increase in XO-induced oxidative stress can then inhibit HSP90 interactions with eNOS, decreasing *NO generation and predisposing the lung to vaso-occlusion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12972407     DOI: 10.1152/ajplung.00288.2002

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  35 in total

1.  Sickle cell vaso-occlusive crisis induces the release of circulating serum heat shock protein-70.

Authors:  Adeboye H Adewoye; Elizabeth S Klings; Harrison W Farber; Elizabeth Palaima; Maria A Bausero; Lillian McMahon; Adam Odhiambo; Safaya Surinder; Mark Yoder; Martin H Steinberg; Alexzander Asea
Journal:  Am J Hematol       Date:  2005-03       Impact factor: 10.047

2.  Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.

Authors:  Mark T Gladwin; Gregory J Kato
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2005

Review 3.  cGMP modulation therapeutics for sickle cell disease.

Authors:  Nicola Conran; Lidiane Torres
Journal:  Exp Biol Med (Maywood)       Date:  2019-01-28

4.  Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse penis.

Authors:  Biljana Musicki; Tongyun Liu; Sena F Sezen; Arthur L Burnett
Journal:  J Sex Med       Date:  2012-05-23       Impact factor: 3.802

5.  Cough and wheeze events are temporally associated with increased pain in individuals with sickle cell disease without asthma.

Authors:  Robert T Diep; Sudharani Busani; Jena Simon; Alexa Punzalan; Gwen S Skloot; Jeffrey A Glassberg
Journal:  Br J Haematol       Date:  2015-03-05       Impact factor: 6.998

6.  Sickle erythrocytes and platelets augment lung leukotriene synthesis with downregulation of anti-inflammatory proteins: relevance in the pathology of the acute chest syndrome.

Authors:  Michael Opene; Joseph Kurantsin-Mills; Sumair Husain; Basil O Ibe
Journal:  Pulm Circ       Date:  2014-09       Impact factor: 3.017

7.  Intravenous magnesium for pediatric sickle cell vaso-occlusive crisis: methodological issues of a randomized controlled trial.

Authors:  Oluwakemi Badaki-Makun; J Paul Scott; Julie A Panepinto; T Charles Casper; Cheryl A Hillery; J Michael Dean; David C Brousseau
Journal:  Pediatr Blood Cancer       Date:  2014-01-17       Impact factor: 3.167

8.  Transient receptor potential vanilloid 1 mediates pain in mice with severe sickle cell disease.

Authors:  Cheryl A Hillery; Patrick C Kerstein; Daniel Vilceanu; Marie E Barabas; Dawn Retherford; Amanda M Brandow; Nancy J Wandersee; Cheryl L Stucky
Journal:  Blood       Date:  2011-06-27       Impact factor: 22.113

9.  Effects of experimental asthma on inflammation and lung mechanics in sickle cell mice.

Authors:  Kirkwood A Pritchard; Thom R Feroah; Sandhya D Nandedkar; Sandra L Holzhauer; William Hutchins; Marie L Schulte; Robert C Strunk; Michael R Debaun; Cheryl A Hillery
Journal:  Am J Respir Cell Mol Biol       Date:  2011-10-27       Impact factor: 6.914

10.  Wheezing and asthma are independent risk factors for increased sickle cell disease morbidity.

Authors:  Jeffrey A Glassberg; Annie Chow; Juan Wisnivesky; Ronald Hoffman; Michael R Debaun; Lynne D Richardson
Journal:  Br J Haematol       Date:  2012-09-12       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.